These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11990311)

  • 1. Lineage-specific trisomy 21 in a neonate with resolving transient myeloproliferative syndrome.
    Slayton WB; Spangrude GJ; Chen Z; Greene WF; Virshup D
    J Pediatr Hematol Oncol; 2002; 24(3):224-6. PubMed ID: 11990311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disomic homozygosity in 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome.
    Abe K; Kajii T; Niikawa N
    Hum Genet; 1989 Jul; 82(4):313-6. PubMed ID: 2525515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study.
    Kempski HM; Craze JL; Chessells JM; Reeves BR
    Br J Haematol; 1998 Nov; 103(2):473-9. PubMed ID: 9827922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
    Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
    PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down's syndrome.
    Richards M; Welch J; Watmore A; Readett D; Vora AJ
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F215-7. PubMed ID: 10194996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient myeloproliferative disorder with partial trisomy 21.
    Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
    Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 21 in transient myeloproliferative disorder.
    Faed MJ; Robertson J; Todd AS; Sivakumaran M; Tarnow-Mordi WO
    Cancer Genet Cytogenet; 1990 Sep; 48(2):259-64. PubMed ID: 2144465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo dicentric chromosome (5;21): a rare example of maternal germline mosaicism.
    Engel U; Bohlander SK; Bink K; Hinney B; Laccone F; Bartels I
    Hum Reprod; 2001 Jan; 16(1):63-66. PubMed ID: 11139538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mapping of the gene for transient myeloproliferative syndrome at 21q11.2.
    Niikawa N; Deng HX; Abe K; Harada N; Okada T; Tsuchiya H; Akaboshi I; Matsuda I; Fukushima Y; Kaneko Y
    Hum Genet; 1991 Sep; 87(5):561-6. PubMed ID: 1680787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient myeloproliferative disorder as the presenting feature for mosaic trisomy 21.
    Baca N; Sanchez-Lara PA; Schreck R; Eno CC; Majlessipour F
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34789514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate.
    Polski JM; Galambos C; Gale GB; Dunphy CH; Evans HL; Batanian JR
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):50-4. PubMed ID: 11902741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient myeloproliferative disorder in chromosomally normal newborn infant.
    Kalousek DK; Chan KW
    Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia.
    Minelli A; Morerio C; Maserati E; Olivieri C; Panarello C; Bonvini L; Leszl A; Rosanda C; Lanino E; Danesino C; Pasquali F
    Leukemia; 2001 Jun; 15(6):971-5. PubMed ID: 11417485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaicism for trisomy 21 and ring (21) in a male born to normal parents: a case report.
    Samarth RM; Gandhi P; Pandey H; Maudar KK
    Gene; 2012 Dec; 511(1):109-12. PubMed ID: 23000017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosome 21 mosaicism. A review].
    Kovaleva NV
    Tsitologiia; 2003; 45(4):434-40. PubMed ID: 14520876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.
    Corazza F; Astolfi A; Libri V; Franzoni M; Serravalle S; Alessandroni R; Melchionda F; Pession A
    Int J Hematol; 2014 Jun; 99(6):794-7. PubMed ID: 24771229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21.
    Girodon F; Favre B; Couillaud G; Carli PM; Parmeland C; Maynadié M
    Cytometry; 2000 Apr; 42(2):118-22. PubMed ID: 10797450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient leukemia in newborns without down syndrome: diagnostic and management challenges.
    Williams BA; Meyn MS; Hitzler JK
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e261-3. PubMed ID: 21768885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.